Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Strayer

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Interferon Research|August 1, 1986
Antiproliferative effect of mismatched double-stranded RNA on fresh human tumor cells analyzed in a clonogenic assayD R Strayer, P Watson, W A Carter, et al.
Journal of Biological Response Modifiers|December 1, 1985
Clinical studies with ampligen (mismatched double-stranded RNA)I Brodsky, D R Strayer, L J Krueger, et al.
British Journal of Haematology|March 1, 1982
Quantitation of RNA-dependent platelet DNA polymerase in patients with myeloproliferative disordersD R Strayer, I Brodsky, M J Caranfa, et al.
Cancer Genetics and Cytogenetics|May 1, 1987
Implications of retroviral and oncogene activity in chronic myelogenous leukemiaI Brodsky, H R Hubbell, D R Strayer, et al.
Journal of Biological Response Modifiers|October 1, 1985
Preclinical studies with Ampligen (mismatched double-stranded RNA)W A Carter, D R Strayer, H R Hubbell, et al.
Cancer Research|June 1, 1985
Antiproliferative and immunomodulatory actions of beta-interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude miceH R Hubbell, K Kvalnes-Krick, W A Carter, et al.
Journal of Biological Response Modifiers|December 1, 1985
Comparative studies of ampligen (mismatched double-stranded RNA) and interferonsW A Carter, H R Hubbell, L J Krueger, et al.
Cancer Research|January 1, 1984
Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancerD R Strayer, W A Carter, S D Mayberry, et al.
JAMA|April 6, 1984
Carcinoid tumor response to fibroblast interferonD R Strayer, W A Carter, I Brodsky, et al.
Lancet (London, England)|April 18, 1987
Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virusW M Mitchell, D C Montefiori, W E Robinson, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Interferon Research|August 1, 1986
Antiproliferative effect of mismatched double-stranded RNA on fresh human tumor cells analyzed in a clonogenic assayD R Strayer, P Watson, W A Carter, et al.
Journal of Biological Response Modifiers|December 1, 1985
Clinical studies with ampligen (mismatched double-stranded RNA)I Brodsky, D R Strayer, L J Krueger, et al.
British Journal of Haematology|March 1, 1982
Quantitation of RNA-dependent platelet DNA polymerase in patients with myeloproliferative disordersD R Strayer, I Brodsky, M J Caranfa, et al.
Cancer Genetics and Cytogenetics|May 1, 1987
Implications of retroviral and oncogene activity in chronic myelogenous leukemiaI Brodsky, H R Hubbell, D R Strayer, et al.
Journal of Biological Response Modifiers|October 1, 1985
Preclinical studies with Ampligen (mismatched double-stranded RNA)W A Carter, D R Strayer, H R Hubbell, et al.
Cancer Research|June 1, 1985
Antiproliferative and immunomodulatory actions of beta-interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude miceH R Hubbell, K Kvalnes-Krick, W A Carter, et al.
Journal of Biological Response Modifiers|December 1, 1985
Comparative studies of ampligen (mismatched double-stranded RNA) and interferonsW A Carter, H R Hubbell, L J Krueger, et al.
Cancer Research|January 1, 1984
Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancerD R Strayer, W A Carter, S D Mayberry, et al.
JAMA|April 6, 1984
Carcinoid tumor response to fibroblast interferonD R Strayer, W A Carter, I Brodsky, et al.
Lancet (London, England)|April 18, 1987
Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virusW M Mitchell, D C Montefiori, W E Robinson, et al.
Pageof 4